tiprankstipranks
Trending News
More News >
Kalaris Therapeutics (KLRS)
NASDAQ:KLRS
US Market
Advertisement

Kalaris Therapeutics (KLRS) Similar Stocks

Compare
358 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Kalaris Therapeutics
$4.90
$77.50M
-72.50%
3 Buy
1 Hold
0 Sell
Strong Buy
Coherus Biosciences
$1.79
$191.77M
5.55
103.41%
3 Buy
0 Hold
0 Sell
Strong Buy
Nektar Therapeutics
$62.99
$1.20B
202.11%
6 Buy
1 Hold
1 Sell
Moderate Buy
Cellectis SA
$3.95
$286.68M
114.67%
1 Buy
2 Hold
0 Sell
Moderate Buy
Seres Therapeutics
$18.52
$165.55M
13.83%
2 Buy
0 Hold
0 Sell
Moderate Buy
Kodiak Sciences
$17.70
$934.94M
382.29%
1 Buy
4 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KLRS
Kalaris Therapeutics
4.90
-12.92
-72.50%
CHRS
Coherus Biosciences
1.79
0.91
103.41%
NKTR
Nektar Therapeutics
62.99
42.14
202.11%
CLLS
Cellectis SA
3.95
2.11
114.67%
MCRB
Seres Therapeutics
18.52
2.25
13.83%
KOD
Kodiak Sciences
17.70
14.03
382.29%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis